Quick answers
- What is Umeclidinium and Vilanterol Ellipta?
- Umeclidinium and Vilanterol Ellipta is a brand name of Umeclidinium bromide and vilanterol trifenatate, a prescription medicine. The FDA NDC Directory lists 1 Umeclidinium and Vilanterol Ellipta product in 1 strength and form.
- Who makes Umeclidinium and Vilanterol Ellipta?
- Glaxosmithkline holds the FDA application for Umeclidinium and Vilanterol Ellipta (NDA203975, approved December 18, 2013).
- Is there a generic or store brand of Umeclidinium and Vilanterol Ellipta?
- Yes. The FDA NDC Directory lists 1 other product with the same active ingredients, strength and form as a Umeclidinium and Vilanterol Ellipta product. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Umeclidinium and Vilanterol Ellipta?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Umeclidinium and Vilanterol Ellipta strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Umeclidinium and Vilanterol Ellipta been recalled?
- No recall linked to Umeclidinium and Vilanterol Ellipta products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Umeclidinium and Vilanterol Ellipta is
Each Umeclidinium and Vilanterol Ellipta product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Umeclidinium bromide and vilanterol trifenatate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| umeclidinium bromide 62.5 ug · vilanterol trifenatate 25 ug powder (respiratory (inhalation)) | Umeclidinium and Vilanterol Ellipta | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Umeclidinium bromide and vilanterol trifenatate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA203975 | Glaxosmithkline | December 18, 2013 | 1 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| umeclidinium bromide 62.5 ug · vilanterol trifenatate 25 ug powder | Generic: Umeclidinium and Vilanterol Ellipta | $4.94 per unit Generic of the same strength and form: $4.94 per unit |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Umeclidinium and Vilanterol Ellipta
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Umeclidinium and Vilanterol Ellipta products.
- Prasco Laboratories1 product
Recalls
No recall linked to Umeclidinium and Vilanterol Ellipta products (by their NDC code or label) appears in the FDA enforcement reports.
Next steps
- Umeclidinium bromide and vilanterol trifenatateThe medicine itself: side effects, interactions, dosage and generics
- Find a pharmacy near youAsk which price applies to you
- Latest FDA drug recallsNewest first
- All brand-name medicinesSearch by brand or product name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.